The table below provides data indicating the use of Major Depressive Disorder (MDD) diagnosis code
assignment for years 1 and 2 of an ambulatory CDI program. Based on the data and if the HCC value
assigned to MDD was 0.299, which of the following should be inferred?
A.
The number of patients increased with an equal increase in use of MDD specified and a decrease in MDD, unspecified, not impacting future cost benchmarking.
B.
The number of patients increased with an increase in use of MDD specified and a decrease in MDD, unspecified, impacting future cost benchmarking.
C.
The number of patients increased with the difference between MDD specified and MDD, unspecified insignificant, not impacting future cost benchmarking.
D.
The number of patients increased with an increase in use of MDD specified and an increase in MDD, unspecified, impacting future cost benchmarking.
Correct Answer: B
Explanation:
Year 2 shows a higher total volume of MDD diagnoses (185,090 vs. 155,501), but the key CDI signal is
the shift in coding specificity: “MDD, specified” increases substantially (118,516 vs. 76,318), while
“MDD, unspecified” decreases (66,574 vs. 79,193). In outpatient CDI terms, this pattern is consistent
with improved documentation quality and code capture—providers are describing the condition with
greater clinical detail (episode type, severity, remission status, recurrence, etc.), allowing assignment
of more specific ICD codes. When an HCC value (0.299) is associated with MDD, improved capture of
qualifying, specific MDD codes supports more accurate risk adjustment. That increases the accuracy
of projected resource need and affects future cost benchmarking (and potentially quality/utilization
comparisons) because the population’s documented burden of illness is better represented.
Question #2 (Topic: demo questions)
A patient returns to a PCP for follow-up care related to a UTI. The provider documents “stage 3 CKD”
as determined by a single eGFR of 52 mL/min. Which of the following actions should the CDI
specialist take?
A.
Add diagnosis of CKD stage 3 to claim, as it is reportable.
B.
Review CKD staging criteria with provider.
C.
Delete CKD diagnosis from claim as it was not treated during this encounter.
D.
Query for stage 4 CKD.
Correct Answer: B
Explanation:
Outpatient CDI guidance emphasizes that documentation must reflect a condition that is
clinically valid, supported by the record, and accurately described, especially for chronic diseases. CKD
is generally established by evidence of decreased kidney function or kidney damage that is persistent,
not a one-time lab that could be affected by hydration status, acute illness, medications, or transient
physiologic changes. While an eGFR of 52 falls within the numeric range commonly associated with
stage 3a, the key CDI issue is the foundation for diagnosing chronic disease, not simply whether the
number is “reportable.” Option A inappropriately directs CDI to add diagnoses to claims; CDI supports
providers and coding, but does not independently “add” conditions. Option C is incorrect because
chronic conditions may be coded when addressed/impact care, not only when actively treated. Option
D is unsupported because eGFR 52 does not suggest stage 4.
Question #3 (Topic: demo questions)
A patient with a PMH of DM, GERD, and HTN is seen in the clinic with complaints of stuffy nose,
fever, and feeling tired for the past four days. The patient’s medication list includes SSI, Prilosec, and
Diovan. The provider documented: “Congestion, fever, malaise, DM, GERD, HTN. Continue OTC
medications for congestion and fever. Rest. Return to the clinic in one week if symptoms persist.”
Which of the following ICD-10-CM guidelines BEST applies to how this scenario should be coded
A.
Selection of first-listed condition
B.
Codes that describe symptoms and signs
C.
Uncertain diagnose
Correct Answer: B
Explanation:
In the outpatient setting, when the provider does not document a definitive diagnosis for the acute
complaint (e.g., influenza, sinusitis, URI), ICD-10-CM guidance directs coders to report the signs and
symptoms that are documented and addressed. Here, the clinician documents congestion, fever, and
malaise and provides treatment instructions for those symptoms (OTC meds, rest, follow-up). That
makes the symptom codes the most appropriate representation of the reason for the encounter.
Outpatient CDI principles further emphasize that chronic conditions like DM, GERD, and HTN should
only be coded when the documentation shows they were evaluated, monitored, assessed/managed,
or treated during the visit (e.g., status, control, medication adjustment, related testing, counseling).
In this note, the plan targets only the acute symptoms and does not demonstrate active
management of the chronic conditions beyond listing history/medications. Therefore, the guideline
most directly applicable to correct coding of the encounter is codes that describe symptoms and
si g ns
Question #4 (Topic: demo questions)
A 76-year-old patient presents for a wellness visit. The patient’s vitals are BP 120/80, T 98.7, R 19, and there are no abnormal findings in the exam. The patient has COPD, home oxygen, anemia,
hypertension, diabetes, fatigue, and weakness. The patient’s medications are called into the
pharmacy and home health resource of choice. Which of the following is the BEST query option?
A.
Acute blood loss anemia
B.
Peripheral neuropathy
C.
Chronic respiratory failure
D.
CKD
Correct Answer: C
Explanation:
The best query is chronic respiratory failure because home oxygen is a strong clinical indicator that
often reflects an underlying chronic hypoxemic condition beyond uncomplicated COPD. Outpatient
CDI guidance stresses that queries should be driven by present clinical indicators in the note and
should seek clarification that impacts accurate diagnosis capture and ongoing care. Here, the
provider documents COPD plus home oxygen and is arranging continued services (medication
management and home health), which supports asking whether the patient has a reportable
condition such as chronic respiratory failure with hypoxia (or COPD with chronic hypoxemia) and
whether it is being monitored/managed. The other options lack support: acute blood loss anemia
has no bleeding, hemodynamic instability, or acute findings; peripheral neuropathy is not assessed or
described despite diabetes; and CKD has no labs, staging, history, or assessment. A compliant query
would be non-leading and include the indicator (home O₂) and request the most accurate diagnosis
and specificity/status.